Skip to main content
Journal cover image

The American Brachytherapy Society (ABS) consensus guidance for hybrid intracavitary interstitial brachytherapy for locally advanced cervical cancer.

Publication ,  Journal Article
Chino, J; Erickson, B; Gaffney, D; Hsu, I-C; Kamrava, M; Kim, Y; Niedermayr, TR; Roumeliotis, M; Rownd, J; Todor, D; Viswanathan, A; Kidd, EA
Published in: Brachytherapy
2025

PURPOSE: The purpose of this consensus statement from the American Brachytherapy Society (ABS) is to summarize important considerations for adding interstitial needles to intracavitary implants for cervix cancer brachytherapy. METHODS: A panel of experts in Gynecologic Brachytherapy, including both physicians and physicists completed surveys and met virtually on multiple occasions to discuss and define current practices and approaches in order to summarize these for the ABS community. This document was drafted, reviewed and approved by the full panel and the ABS Board of Directors. RESULTS: Hybrid brachytherapy is increasingly being utilized in cervix brachytherapy. In incorporating supplementary interstitial needles there are numerous key considerations including resources for an emergency, planning considerations, applicator selection, and pre-, intra- and postprocedural imaging. Additionally, approaches to challenging cases that would often benefit from a hybrid approach are discussed. CONCLUSIONS: While hybrid brachytherapy offers dosimetric advantages for cervix brachytherapy, it increases procedure complexity. Being aware of the necessary resources and defining considerations can help mitigate some of the challenges and improve procedural success.

Duke Scholars

Published In

Brachytherapy

DOI

EISSN

1873-1449

Publication Date

2025

Volume

24

Issue

4

Start / End Page

463 / 478

Location

United States

Related Subject Headings

  • Uterine Cervical Neoplasms
  • United States
  • Societies, Medical
  • Radiotherapy Dosage
  • Oncology & Carcinogenesis
  • Humans
  • Female
  • Consensus
  • Brachytherapy
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chino, J., Erickson, B., Gaffney, D., Hsu, I.-C., Kamrava, M., Kim, Y., … Kidd, E. A. (2025). The American Brachytherapy Society (ABS) consensus guidance for hybrid intracavitary interstitial brachytherapy for locally advanced cervical cancer. Brachytherapy, 24(4), 463–478. https://doi.org/10.1016/j.brachy.2025.05.001
Chino, Junzo, Beth Erickson, David Gaffney, I-Chow Hsu, Mitchell Kamrava, Yongbok Kim, Thomas R. Niedermayr, et al. “The American Brachytherapy Society (ABS) consensus guidance for hybrid intracavitary interstitial brachytherapy for locally advanced cervical cancer.Brachytherapy 24, no. 4 (2025): 463–78. https://doi.org/10.1016/j.brachy.2025.05.001.
Chino J, Erickson B, Gaffney D, Hsu I-C, Kamrava M, Kim Y, et al. The American Brachytherapy Society (ABS) consensus guidance for hybrid intracavitary interstitial brachytherapy for locally advanced cervical cancer. Brachytherapy. 2025;24(4):463–78.
Chino, Junzo, et al. “The American Brachytherapy Society (ABS) consensus guidance for hybrid intracavitary interstitial brachytherapy for locally advanced cervical cancer.Brachytherapy, vol. 24, no. 4, 2025, pp. 463–78. Pubmed, doi:10.1016/j.brachy.2025.05.001.
Chino J, Erickson B, Gaffney D, Hsu I-C, Kamrava M, Kim Y, Niedermayr TR, Roumeliotis M, Rownd J, Todor D, Viswanathan A, Kidd EA. The American Brachytherapy Society (ABS) consensus guidance for hybrid intracavitary interstitial brachytherapy for locally advanced cervical cancer. Brachytherapy. 2025;24(4):463–478.
Journal cover image

Published In

Brachytherapy

DOI

EISSN

1873-1449

Publication Date

2025

Volume

24

Issue

4

Start / End Page

463 / 478

Location

United States

Related Subject Headings

  • Uterine Cervical Neoplasms
  • United States
  • Societies, Medical
  • Radiotherapy Dosage
  • Oncology & Carcinogenesis
  • Humans
  • Female
  • Consensus
  • Brachytherapy
  • 3202 Clinical sciences